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ABSTRACT
Objectives: We examined abruption risk in relation to
change in paternity, and evaluated if birth interval
confounds this association.
Setting: Population-based study of singleton births in
Norway between 1967 and 2009.
Participants: Women who had their first two
(n=747 566) singleton births in the Norwegian Medical
Birth Registry. The associations between partner
change between pregnancies and birth interval were
examined in relation to abruption in a series of logistic
regression models.
Primary outcome measures: Risk, as well as
unadjusted and adjusted OR of placental abruption in
relation to change in paternity and interval between
births.
Results: Among women without abruption in their
first pregnancy, the risks of abruption in the second
pregnancy were 4.7 and 6.5 per 1000 in women who
had the same and different partners, respectively
(OR=1.39, 95% CI 1.26 to 1.53). After adjustments for
confounders including birth interval and smoking,
partner change was not associated with abruption
(OR=1.01, 95% CI 0.79 to 1.32). Among women with
abruption in the first pregnancy, the association
between partner change and abruption in the second
pregnancy was 0.98 (95% CI 0.75 to 1.28). Interval
<1 year was associated with increased abruption risk in
the second pregnancy among women with the same as
well as different partners, but interval over 4 years was
only associated with increased risk among women with
the same partner. No such patterns were seen for
recurrent abruption.
Conclusions: We find no evidence that a change in
partner is associated with increased abruption risk.
Theories supporting an immune maladaptation
hypothesis afforded by change in paternity are not
supported insofar as abruption is concerned.
INTRODUCTION
Placental abruption, the premature separ-
ation of the implanted placenta prior to deliv-
ery of the fetus, complicates 4–12 per 1000
pregnancies.1–4 Abruption is a devastating
obstetrical complication, with such pregnan-
cies ending roughly 2–4 weeks earlier and
newborns weighing 400–600 g less in com-
parison with otherwise uncomplicated preg-
nancies.5 This early delivery as a consequence
of abruption, in turn, is associated with dis-
proportionately increased risks of perinatal
mortality,6 as well as cerebral palsy7 and devel-
opmental delays during childhood.8 Women
who suffer an abruption are at increased risks
of premature death from cardiovascular and
cerebrovascular complications later in life.9 10
Since placental abruption is a condition that
involves the placenta, a postulation that its aeti-
ology may likely bear both a maternal and fetal
contribution, at least partly inherited from the
father, appears reasonable. Evidence for this
line of reasoning can also be found in studies
that have shown that abruption has an
immunological underpinning.11 The argu-
ment to support an immune-mediated process
to abruption is that the maternal immune
system adapts to paternal antigens through
imprinting in pregnancies with extended
periods of sexual cohabitation. When women
change partners between pregnancies, they
are exposed to a new set of paternal antigens
likely contributing to increased abruption risk.
Strengths and limitations of this study
▪ Large, population-based prospective cohort
study with almost 750 000 women who delivered
their first two singleton births in Norway.
▪ This study sheds light regarding the association
between change in paternity and abruption risk,
and the role of interval between births.
▪ The prevalence rate of placental abruption is low
in this cohort.
▪ In about 1.7% of pregnancies we were unable to
assign the correct paternity.
▪ The possibility of the findings affected by
residual confounding is likely.
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However, studies of partner change and adverse perinatal
end points often fail to incorporate adjustments for one
of the strongest known confounders—birth interval.12
A change in partner between pregnancies inevitably alters
the interval between births. In comparison to women who
remain with the same partners, those who change partners
between pregnancies are different as regards sociodemo-
graphic and behavioural factors, and lifestyle character-
istics. These women, in general, are older, less educated
and more likely to smoke in comparison to those who do
not change partners.13 14
Even within the group that changes partners, women
with very short birth intervals may be a distinctly differ-
ent set from those with relatively longer intervals. The
higher risk of abruption in women with short intervals
may suggest nutritional deﬁciencies, including those
that involve the folate metabolism pathway, and a
uterine environment not optimally primed to carry the
next pregnancy to a successful delivery. Folate deﬁciency,
especially 3 months before pregnancy and during the
ﬁrst trimester,15 and genes that regulate folate metabol-
ism,16–19 are associated with increased abruption risk.
However, a change in partner invariably prolongs the
time to the next pregnancy and leads to longer birth
intervals. Although the pathways through which extended
intervals may confer increased abruption risk are unclear,
we suspect that the longer interval may reﬂect increased
subfertility in these couples, especially among those with
the same partner. Furthermore, it is likely that with
uterine ageing (attributed to previous pregnancies and
extended interval between pregnancies), the physio-
logical capacity to reproduce may decline.
Indeed, if the risk of abruption increases with a
change in partner between pregnancies, then the
immune adaptation pathway may provide important
clues. Nevertheless, we hypothesise that the increased
abruption risk in relation to change in paternity may
simply be a manifestation of strong confounding attribu-
ted to interval between births. We test this hypothesis in
a large population-based prospective cohort study of
births in Norway.
METHODS
This study is based on a prospective cohort, with data
derived from the Medical Birth Registry of Norway
(MBRN), comprised of approximately 2.2 million births
between 1967 and 2009. Notiﬁcation to the MBRN is
compulsory, and data on births is completed using a
standardised notiﬁcation form.20 The notiﬁcation form
was unchanged from 1967 to 1998, and data were mostly
notiﬁed as free text speciﬁcations to items such as
‘Maternal health before pregnancy,’ ‘Maternal health
during pregnancy’ and ‘Complications in relation to
birth’. In 1999, a revised notiﬁcation form was intro-
duced, which contained a few additional items such as
maternal smoking habits and ultrasound-estimated due
dates, and check boxes were introduced in addition to
free text. Electronic birth notiﬁcation, where predeﬁned
variables replaced the check boxes, has been used for
an increasing proportion of births since 2006, but
except for the inclusion of maternal weight and height,
the content has been unchanged since 1998.
In Norway, every individual is assigned a unique
national identiﬁcation number at birth, which is regis-
tered in the Central Person Registry. This identiﬁcation
number enables linking successive pregnancies to the
same woman. The MBRN is routinely linked with the
Central Person Registry, and through this linkage, identi-
ﬁcation numbers of all fathers are collected as well as all
dates of deaths. We also used the identiﬁcation numbers
to link the MBRN with the National Education
Database, Statistics Norway, where educational level of
all individuals in Norway has been registered since 1970.
Any education completed in Norway is registered when
the individual is 16 years of age, and this information is
updated yearly. Missing information in the education
database is mainly found in immigrants who have
recently come to the country and who have not com-
pleted any education in Norway.
Definition of placental abruption
Placental abruption was deﬁned as the premature separ-
ation of an implanted placenta prior to delivery of the
fetus. During 1967–1998, data on abruption was notiﬁed
to the registry in free text as a speciﬁcation to the item:
‘Complications in relation to birth’. Since 1999, abrup-
tion was notiﬁed using a check box (or a predeﬁned
value) or in free text. Data in free text were coded at the
MBRN using the International Classiﬁcation of Diseases
(ICD) 8th revision, for births delivered before 1999, and
the ICD 10th revision for births from 1999 onwards.
Change in paternity
Change in paternity was deﬁned as women who
changed their partner between births. Cohabiting and
married couples were treated equally. The MBRN ascer-
tains the national identiﬁcation numbers of the woman’s
husband or cohabiting partner through routine linkage
with the Central Person Registry. For live births, who get
their national identiﬁcation number at birth and thus
can be identiﬁed in the Central Person Registry, infor-
mation on the father is collected automatically through
the linkage. For stillbirths, which do not get a national
identiﬁcation number, the fathers’ identiﬁcation
numbers are collected on the basis of information on
the birth notiﬁcation form regarding father’s name and
birth date. This information is used in a manual search
in the Central Person Registry to ﬁnd the full identiﬁca-
tion number.
During the study period, of the 747 566 women who
had their ﬁrst and second singleton births, 89.1%
(n=666 401) had the same partner for both pregnancies,
9.2% (n=68 663) changed partners between pregnancies
and for 12 502 (1.7%) women we were unable to assign
paternity status.
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Definition of birth interval
Birth interval was calculated as the time between con-
secutive birth dates (calculated in days and subsequently
converted to years). In other words, a birth interval of
3 years corresponds to a period of 3 years but less than 4
completed years. Given the 100% completeness in using
dates of birth, rather than approximate dates of concep-
tion, we based our calculation on birth intervals. Since
the focus was on short and long birth intervals, the
effect of using birth date rather than the date of concep-
tion is expected to be minimal.
Statistical analysis
We examined the association of partner change and the
risk of abruption and reported OR with 95% CI derived
from logistic regression models. These preliminary ana-
lyses were followed by a series of sequential adjustments
for confounding factors. First, we adjusted the association
between partner change and abruption for interval
between births (categorised as <1, 1–1.9, 2–2.9, 3–3.9,
4–4.9, 5–5.9, 6–7.9, 8–9.9, 10–12.9 and ≥13 years). This
was followed by further adjustment for maternal age (<20,
20–24, 25–29, 30–34, 35–39 and ≥40 years), maternal edu-
cation (<12, 12–13 and ≥14 years of schooling), marital
status (married/cohabitating, single and others) and
period of birth (1967–1971, 1972–1976,…,2002–2009) to
account for temporal changes in the prevalence of abrup-
tion. All analyses were performed separately for women
with and without abruption in their ﬁrst pregnancy.
Data on maternal smoking, an important risk factor for
abruption,3 21 are recorded in the MBRN only since 1999.
In a subanalysis restricted to births between 1999 and 2009
(n=191 953 women), we evaluated the abruption risk by
partner change, and birth interval after adjusting for
maternal smoking and the aforementioned confounders.
RESULTS
The distribution of maternal characteristics in relation
to the risk of placental abruption in the ﬁrst pregnancy
is shown in table 1. The incidence of abruption showed
a reversed ‘U’-shaped pattern with a peak around 1987–
1991. The risk increased with advancing maternal age
and was higher among single women, smokers (since
1999) and those with a diagnosis of chronic hyperten-
sion, preeclampsia and pregestational diabetes.
Risk of placental abruption following change in paternity
Among women with and without abruption in the ﬁrst
pregnancy, the risks of abruption in the second preg-
nancy were 38.7 and 5.0 per 1000 births, respectively
(table 2). Among women with no abruption in the ﬁrst
pregnancy, the risks of abruption were 4.7 and 6.5 per
1000 in the second pregnancy in women with the same
and different partners, respectively. Among women with
abruption in the ﬁrst pregnancy, the risks of recurrent
abruption among women with the same and different
partners, were 38.4 and 36.9 per 1000, respectively.
Interestingly, the risk of abruption in the second preg-
nancy was higher in women with unknown paternity status.
Among women with no previous abruption, following
adjustment for birth interval, a change in partner was
associated with a 17% (OR 1.17, 95% CI 1.04 to 1.32)
increased risk of abruption in the second pregnancy
(table 3). Further adjustments for other confounding
factors slightly attenuated this risk. However, in a subset
of this cohort restricted to women who had their ﬁrst
two births between 1999 and 2009, when these associa-
tions were additionally adjusted for maternal smoking,
the association of increased abruption risk following a
change in partner completely disappeared. When the
association between partner change and abruption risk
was examined among women with abruption in the ﬁrst
pregnancy, we found that partner change was not asso-
ciated with abruption recurrence.
Influence of birth interval on abruption risk
The risk of abruption in relation to interval between
births shows a reversed ‘J’-shaped pattern (ﬁgure 1).
Among women with no previous abruption and with the
same partner, the risk of abruption in the second preg-
nancy was 14.2 per 1000 for an interval <1 year and the
risk sharply declined with increasing interval, reaching a
nadir at 3–4 years (4 per 1000) and began to rise there-
after. Among women who changed partners, the risk of
abruption in the second pregnancy was 25.6 per 1000
for an interval <1 year, and declined sharply and
remained virtually ﬂat with increasing intervals.
We detected an interaction of marginal signiﬁcance
between birth interval and change in paternity on abrup-
tion risk (p=0.045). Therefore, we examined the effects
of birth interval on abruption risk separately among
women with the same and different partners between the
ﬁrst two pregnancies (ﬁgure 2). Among women who did
not change partners between pregnancies and no abrup-
tion in the ﬁrst pregnancy, compared to interval
2–3 years, the odds of abruption in the second pregnancy
with an interval <1 year were 3.4 (95% CI 2.7 to 4.3). As
the pregnancy interval increased to 4 or more years, the
odds of abruption also increased. Among women who
changed partners between pregnancies with no abrup-
tion in the ﬁrst pregnancy, compared to women with
intervals of 2–3 years, the odds of abruption in women
with interval <1 year were 4.8 (95% CI 1.1 to 20.5);
longer intervals were not associated with increased odds
of abruption. These patterns of associations were not
seen for recurrent abruptions (data not shown).
Sensitivity analysis
A variety of factors can shape a couple’s decision to
undergo a pregnancy. Importantly, couples with a peri-
natal loss in one pregnancy continue to have another
pregnancy more often and more quickly to achieve a
desired family size than couples without such losses—a
phenomenon called ‘selective fertility’.22 23 We exam-
ined if bias due to selective fertility may have affected
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our ﬁndings. After excluding women with a perinatal
loss (stillbirth or deaths within the ﬁrst month), the asso-
ciations between change in paternity between the ﬁrst
two births and abruption risk remained unchanged.
These results were also similar in another analysis after
excluding women with a diagnosis of preeclampsia in
the ﬁrst pregnancy, as well as women who had spontan-
eous abortions in the ﬁrst trimester.
DISCUSSION
In this large population-based cohort of singleton births
in Norway, following adjustments for smoking and other
confounders, women who change partners between
their ﬁrst two pregnancies are not at increased risk of
developing abruption in the second pregnancy. We also
show that regardless of partner change, birth interval
<1 year is strongly associated with increased risk of
abruption, but this association was conﬁned to women
with no abruption in their ﬁrst pregnancy. Intervals
longer than 4 years are also associated with increased
risk, although this association was only seen among
women who did not change partners.
The mother and the father each play important roles
in the implantation, development, maturation and subse-
quent detachment of the placenta. While placental
Table 1 Distribution of maternal characteristics in relation to placental abruption in the first singleton pregnancy: Norway,
1967–2009
Maternal characteristics
in the first pregnancy
Total births
(n=988 027)
Placental abruption in the first pregnancy
Number (n=5327) Risk per 1000 births OR (95% CI)
Period of delivery
1967–1971 128 344 637 5.0 1.3 (1.2 to 1.4)
1972–1976 122 941 634 5.2 1.3 (1.2 to 1.5)
1977–1981 105 412 602 5.7 1.5 (1.3 to 1.7)
1982–1986 106 715 720 6.7 1.8 (1.6 to 2.0)
1987–1991 123 474 869 7.0 1.8 (1.7 to 2.0)
1992–1996 119 084 685 5.8 1.5 (1.3 to 1.6)
1997–2001 109 060 513 4.7 1.2 (1.1 to 1.4)
2002–2009 172 997 668 3.9 1.0 (Referent)
Maternal age (years)
<20 127 127 714 5.6 1.1 (1.1 to 1.3)
20–24 383 943 2039 5.3 1.1 (1.0 to 1.2)
25–29 314 625 1547 4.9 1.0 (Referent)
30–34 123 999 748 6.0 1.2 (1,1 to 1.3)
35–39 33 054 234 7.3 1.4 (1.3 to 1.7)
≥40 5278 46 8.1 1.8 (1.3 to 2.4)
Education (years)
<12 387 224 2408 6.2 1.3 (1.3 to 1.4)
12 243 918 1261 5.2 1.1 (1.0 to 1.2)
≥13 332 478 1548 4.7 1.0 (Referent)
Marital status
Married/cohabitating 820 580 4193 5.0 1.0 (Referent)
Single 159 172 1080 6.8 1.3 (1.2 to 1.4)
Others 8275 55 6.6 1.3 (1.0 to 1.7)
Chronic hypertension
Absent 985 482 5300 5.4 1.0 (Referent)
Present 2545 28 11.0 2.1 (1.4 to 3.0)
Preeclampsia
Absent 945 461 4770 5.0 1.0 (Referent)
Present 42 566 558 13.1 2.6 (2.4 to 2.9)
Pregestational diabetes
Absent 984 309 5296 5.4 1.0 (Referent)
Present 3519 31 8.8 1.6 (1.2 to 2.3)
Gestational diabetes
Absent 984 752 5311 5.4 1.0 (Referent)
Present 3275 17 5.2 1.0 (0.6 to 1.6)
Smoking history (1999–)
Non-smoker 163 038 588 3.6 1.0 (Referent)
Daily smoker 2498 18 7.2 2.0 (1.3 to 3.2)
Occasional smoker 19 470 101 5.2 1.5 (1.2 to 1.8)
Unknown 51 370 2294 4.5 1.2 (1.1 to 1.4)
Data restricted to women who delivered singleton births.
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implantation is under the control of maternal genes, the
growth of membranes surrounding the embryo is primar-
ily inﬂuenced by paternal genes.24 25 Since abruption is a
condition that involves the placenta, a study of maternal
and paternal contributions is important to understand
the causes of the inadequate placental attachment and
premature placental detachment—both of which can
lead to the syndrome of placental abruption.26 27
Limitations of the data
Despite the sheer size of the cohort, a few important
limitations of the study exist. First, the prevalence of
abruption in this Norwegian cohort (5 per 1000) is
somewhat lower than that reported in the USA28 and
Canada29 (7–13 per 1000), but consistent with rates
reported in Sweden1 21 and Finland.30 Although variabil-
ity in the criteria for ascertainment of abruption may
account for such differences in prevalence rates, we
suspect that these differences may be due to differences
in maternal sociodemographic characteristics and clin-
ical proﬁles. Second, an abruption diagnosis was
extracted from free-text data between 1967 and 1998,
and using a check box, in addition to free text since
1999 in the Medical Birth Registry. However, temporal
trends of registered abruption prevalence in the MBRN
do not show any particular change in 1999 (http://
mfr-nesstar.uib.no/mfr/). Third, since ultrasound (for
diagnosing abruption) was unavailable during the
earlier periods of the study, the diagnosis of abruption
may have been subject to more misclassiﬁcation in the
earlier rather than later periods in the study. Fourth, we
were unable to assess paternity status in 1.7% of births in
Norway. Although this proportion is small, the preva-
lence rate of abruption in this missing paternity group
was about twofold higher in comparison to births for
which paternity status was recorded.
The associations we report of partner change, interval
between births and abruption risk may have been affected
by residual confounding. Speciﬁcally, these covariates
include maternal prepregnancy body mass index, subferti-
lity and smoking and drug use during pregnancy.
Although data on these confounders were unavailable in
the entire cohort, we were able to adjust for smoking in an
analysis restricted to women who gave birth since 1999.
Strengths of the study
The large cohort of women with successive pregnancies
in Norway spanning over four decades (1967–2009)
afforded an opportunity to study a rare obstetrical com-
plication of abruption in relation to change in paternity
and interval between births. Since virtually all births at
≥16 weeks undergo mandatory reporting to the MBRN,
any study within the registry affords generalisability of
Table 2 Risk of placental abruption among women with the same and different partners between the first and second
pregnancies: Norway, 1967–2009
Interval between
births (median years)
Total pregnancies Abruption in second pregnancy
Number of births Per cent Number of cases Risk per 1000
No abruption in 1st pregnancy
Overall 3.0 747 566 100.0 3723 5.0
Same partner 2.8 666 401 89.1 3110 4.7
Different partners 6.8 68 663 9.2 444 6.5
Unknown status 4.0 12 502 1.7 169 13.5
Abruption in 1st pregnancy
Overall 3.5 4061 100.0 157 38.7
Same partner 3.0 3356 82.6 129 38.4
Different partners 7.1 406 10.0 15 36.9
Unknown status 3.9 299 7.4 13 43.5
Figure 1 Risk of placental abruption (per 1000 births) in the
second pregnancy among women with the same and different
partners: Norway, 1967–2009.
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ﬁndings. Importantly, abruption cases may be subject to
some degree of misclassiﬁcation, but the impact of such
misclassiﬁcation on our ﬁndings remains unknown.
Finally, given that virtually all births in Norway were ana-
lysed, the possibility of our ﬁndings being affected by
selection bias remains low.
Change in paternity and abruption risk
Why might a change in partner be associated with
increased abruption risk? Studies that have reported
such ﬁndings have hypothesised that a cause for such an
association may have to do with a general failure of the
mother to adapt to a new set of paternal antigens in
conjunction with a change in partner.31 In a study com-
paring women diagnosed with preterm abruption
(n=15) with those who had uncontrolled labour (unre-
sponsive to tocolytic administration) and also delivered
at preterm gestational ages (n=33), Steinborn et al32
reported that the proportion of women producing anti-
paternal human leucocyte antigen antibodies was
increased in the preterm abruption (47%) compared to
the preterm labour (14%) group. They concluded that
an increased humoral immune response of the mother
against the fetus may be decisively involved in the patho-
genesis of abruption.32
This immune theory, if true, should also support an
observation that in women who changed partners and
with very short birth interval, there must be a higher risk
of abruption. We see this to be true in our data (ﬁgure 2),
but the risk of abruption is equally high in women who
did not change partners and had a short interval. This sug-
gests that the immune maladaptation theory plays virtually
no role in the pathophysiology of abruption and that birth
interval (and other factors) may have a stronger role in
shaping abruption risk—a ﬁnding that is also supported in
studies of preeclampsia.33
Birth interval and abruption risk
Among women with no abruption in the ﬁrst pregnancy,
we observed an increased risk of abruption in the second
pregnancy among women with short (<1 year) birth
intervals. Maternal nutritional reserves get depleted with
pregnancy, and women with short interval between preg-
nancies do not have adequate time to restore their nutri-
tional reserves. Folates play an important role during
pregnancy, especially during the early stages of concep-
tion where they help in accelerated cell division and
Figure 2 Adjusted OR (95% CI)
of placental abruption in the
second pregnancy in relation to
interval between the first and
second births among women with
no placental abruption in the first
pregnancy: Norway, 1967–2009.
Left panel corresponds to women
with the same partner and the
right panel corresponds to women
who changed partners between
the two pregnancies.
Table 3 Risk of placental abruption in second pregnancy in relation to partner change between the first and second
pregnancies: Norway, 1967–2009
Adjusted OR (95% CI) for placental abruption in second pregnancy
Unadjusted
Adjusted for
birth interval
Complete
adjustment*
Complete adjustment,
1999–2009†
No abruption in 1st pregnancy
Same father 1.00 (Referent) 1.00 (Referent) 1.00 (Referent) 1.00 (Referent)
Different father 1.39 (1.26 to 1.53) 1.17 (1.04 to 1.32) 1.13 (1.00 to 1.28) 1.01 (0.79 to 1.32)
Abruption in 1st pregnancy
Same father 1.00 (Referent) 1.00 (Referent) 1.00 (Referent) 1.00 (Referent)
Different father 0.96 (0.56 to 1.66) 1.35 (0.71 to 2.57) 1.27 (0.66 to 2.44) 0.98 (0.75 to 1.28)
*Adjusted for birth interval, period of birth, maternal age at first birth.
†Adjustments as in previous multivariable model plus smoking (restricted to 1999–2009 data).
6 Ananth CV, et al. BMJ Open 2015;5:e007023. doi:10.1136/bmjopen-2014-007023
Open Access
group.bmj.com on November 19, 2015 - Published by http://bmjopen.bmj.com/Downloaded from 
DNA synthesis.34 Low plasma folate levels, in contrast, are
associated with increased abruption risk,17 35 with results
from a meta-analysis noting an OR of 25.9 (95% CI 0.9 to
736.3) for abruption in relation to folate deﬁciency.19
A large population-based study from Norway15 also
reported reduced abruption risk (OR 0.7, 95% CI 0.6 to
0.8) among women who took folic acid and multivitamin
supplementation during pregnancy.
Despite the associations of increased risk of adverse
perinatal outcomes26 27 including abruption seen in our
study in relation to long birth intervals,28 29 32–37 no con-
vincing hypotheses have been advanced to explain such
an association, nor is one obvious to us. The fact that
this increased risk in second pregnancies was only found
in women with same partners further complicates the
issue. We suspect that subfertility may play a role.
However, we could not ﬁnd any increased risk of abrup-
tion associated with in vitro fertilisation (data not
shown). A pregnancy primes the physiological capacity
for women to reproduce by providing increased capillary
support and uteroplacental blood ﬂow and other adapta-
tions of the reproductive system. Zhu et al36 speculated
that as the interval between births gets longer, the
physiological capacity of women to reproduce
diminishes with ageing of the uterine environment.
Factors other than nutritional deﬁciency may also help
explain the association of long intervals and increased
risk of abruption. These include maternal stress and
anxiety associated with the new pregnancy, and presence
of adverse outcomes in the previous pregnancy, especially
ischaemic placental disorders such as preeclampsia and
fetal growth restriction, all of which lead to early deliv-
ery.38 39 Poor socioeconomic conditions and untoward
behavioural and lifestyle factors that may frequently
accompany women with very short and very long birth
intervals, could also partly explain the associations.
CONCLUSIONS
Following adjustments for interval between births and
other known confounders, a change in paternity
between pregnancies is not associated with abruption. In
contrast, among women with no abruption in their ﬁrst
pregnancy, those with birth intervals less than a year are
at over threefold increased risk for abruption, regardless
of partner change. Adequate nutritional counselling,
coupled with evidence of reduced risk of abruption in
women who consume folate and multivitamin supple-
mentation before and during pregnancy, may help in
reducing the burden of placental abruption and asso-
ciated complications.
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